AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,049 | -5.4% | 406 | +8.3% | 0.00% | – |
Q2 2023 | $10,620 | +44.0% | 375 | +16.8% | 0.00% | – |
Q1 2023 | $7,373 | -23.9% | 321 | -7.0% | 0.00% | – |
Q4 2022 | $9,688 | +7.6% | 345 | +8.5% | 0.00% | – |
Q3 2022 | $9,000 | +50.0% | 318 | +15.2% | 0.00% | – |
Q2 2022 | $6,000 | +20.0% | 276 | +65.3% | 0.00% | – |
Q1 2022 | $5,000 | +400.0% | 167 | +391.2% | 0.00% | – |
Q4 2021 | $1,000 | – | 34 | +183.3% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 12 | -78.6% | 0.00% | – |
Q4 2016 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 56 | -5.1% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q1 2016 | $2,000 | -33.3% | 59 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $3,000 | -50.0% | 59 | -33.7% | 0.00% | 0.0% |
Q3 2015 | $6,000 | -33.3% | 89 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $9,000 | +12.5% | 89 | +3.5% | 0.00% | 0.0% |
Q1 2015 | $8,000 | – | 86 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |